Exclusive: U.S. FTC probes Turing over drug prices, Shkreli’s lawyer says

NEW YORK (Reuters) – The U.S. Federal Trade Commission is investigating Turing Pharmaceuticals for possible antitrust violations in connection with the company’s decision to hike the price of a life-saving drug by more than 5,000 percent, a lawyer for former Chief Executive Officer Martin Shkreli wrote on Friday.

Reuters: Business News

Leave a Reply

Your email address will not be published. Required fields are marked *